Skip to content

XORTX
  • About
    • Management Team
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Coronavirus – COVID-19 Program
    • Autosomal Dominant Polycystic Kidney Disease
    • Diabetic Nephropathy
  • Strategic Partnerships
  • Investors
    • Press Releases
    • Presentations
    • Media
    • Independent Research
    • Financials
    • SEDAR
    • Transfer Agent
    • Upcoming Events
  • Contact
Site Search

Media

FEBRUARY 7, 2020

Robert McWhirter discusses XORTX on BNN

Robert McWhirter, President, Selective Asset Management discusses XORTX on BNN, Friday, February 7th, 2020.

FEBRUARY, 2020

Bruce Rowlands at Capital Events Conferences, Bahamas 2020

https://www.xortx.com/wp-content/uploads/2020/02/XRX-ACIC2020-Reduced.mp4

 

JUNE 11, 2019

Joachim Brunner Interview with Allen Davidoff

XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF) is pleased to share a recent interview with Allen Davidoff, CEO of XORTX by Joachim Brunner. Joachim Brunner, MBA, is a consultant for the PI Value Growth Fund, PI Flexibel Plus and managing director of asset management Portfolio Invest Vermögensmanagement GmbH in Salzburg.

Please note that the introduction to this interview is in German, followed by English.

 

 

 

JUNE 4, 2019 – BIOTUESDAYS, Leonard Zehr

XORTX awaiting key clinical milestones in treating progressive kidney diseases

XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF) is awaiting several key milestones during the next few months as it works to redefine how progressive kidney disease is treated… Read the full article from BIOTUESDAYS here (PDF).

 

https://www.xortx.com/wp-content/uploads/2019/06/2019-06-04_XORTX.mp4

 

 

February, 2019

Bruce Rowlands at Capital Events Conferences, Bahamas 2019

 

Press Releases

  • XORTX Provides Corporate Update January 19, 2021
  • XORTX Grants Options January 12, 2021
  • XORTX Announces Private Placement January 7, 2021
  • XORTX Announces Grant of European Patent December 29, 2020
  • XORTX Announces Topline Results from Mount Sinai’s COVID-19 Clinical Study November 16, 2020
XORTX Therapeutics Inc.
4000, 421 7th Avenue SW
Calgary, Alberta T2P 4K9
Ph: +1 (403) 455-7727
info@xortx.com
Theme by Colorlib Powered by WordPress